Colorado-based kidney-care company DaVita has agreed to pay about $34.5 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce referrals to DaVita Rx, a ...
If you follow DaVita (DVA), you likely noticed its recent removal from the FTSE All-World Index, a move that tends to grab investor attention. Index exclusions matter because they often mean some ...
DaVita, the Denver-based dialysis giant, will pay $34.49 million to settle a lawsuit alleging the company violated anti-kickback laws, the latest in a string of whistleblower settlements for the ...
The U.S. health department's website reported that a ransomware attack between March and April against dialysis provider DaVita Inc. (NYSE:DVA) exposed the personal data of 2.7 million people. On ...
Dialysis company DaVita Inc. issued a statement on Thursday in response to the news Wednesday from Novo Nordisk that its Ozempic treatment for Type 2 diabetes delayed the progression of chronic kidney ...
DaVita has reduced the share count by over 10% in the last six months, but interest expenses increased by 50% Y/Y. International revenues grew by 36% Y/Y, and DaVita is pending regulatory approval to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results